Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Huub van der Mijle"'
Autor:
Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius
Publikováno v:
lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America. To our knowledge, these treatment strategies hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html
Autor:
Yazid Belkacemi, Dominic A.X. Schinagl, Herman Rijna, A. Marinelli, Jean H. G. Klinkenbijl, Grard A. P. Nieuwenhuijzen, Jos W. S. Merkus, Carlo Messina, Marko Snoj, Marieke E. Straver, Willem H. Bouma, Nigel J Bundred, Thijs van Dalen, A. Helen Westenberg, Huub van der Mijle, Nicole Duez, P. Meijnen, Emiel J. Th. Rutgers, Patrick Petignat, Corneel Coens, Robert E. Mansel, Leen Slaets, Lorenzo Orzalesi, Sanne C. Veltkamp, Jan Bogaerts, Luigi Cataliotti, Peter W. de Graaf, Geertjan van Tienhoven, Cornelis J.H. van de Velde, M. Donker
Publikováno v:
Lancet Oncology, 15, 1303-10
Lancet Oncology, 15, 12, pp. 1303-10
The Lancet Oncology, 15(12), 1303-1310
The Lancet Oncology, Vol. 15, No 12 (2014) pp. 1303-1310
lancet oncology, 15(12), 1303-1310. Lancet Publishing Group
Lancet Oncology, 15, 12, pp. 1303-10
The Lancet Oncology, 15(12), 1303-1310
The Lancet Oncology, Vol. 15, No 12 (2014) pp. 1303-1310
lancet oncology, 15(12), 1303-1310. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel node, axillary lymph node dissection is the present standard. Although axillary lymph node dissection provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53caae6015ff98251c49c7a028271756
http://hdl.handle.net/2066/139222
http://hdl.handle.net/2066/139222
Autor:
Huub van der Mijle, Grard A. P. Nieuwenhuijzen, Willem H. Bouma, Cornelis J.H. van de Velde, Emiel J. Th. Rutgers, Lorenzo Orzalesi, A. Helen Westenberg, Saskia Litière, Nicole Duez, Marieke E. Straver, M. Donker, Robert E. Mansel, Geertjan van Tienhoven, Sanne C. Veltkamp, G. Werutsky
Publikováno v:
European Journal of Cancer, 49(9), 2093-2100
Introduction Multifocal breast cancer is associated with a higher risk of nodal involvement compared to unifocal breast cancer and the drainage pattern from multifocal localisations may be different. For this reason, the value of the sentinel node bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7bfbe5905c4228c4eda6d437e36e6b
https://hdl.handle.net/1887/102120
https://hdl.handle.net/1887/102120
Autor:
Robert E. Mansel, Marieke E. Straver, Geertjan van Tienhoven, Helen A. Westenberg, Emiel J. Th. Rutgers, Jean H. G. Klinkenbijl, Huub van der Mijle, Marko Snoj, Cornelis J.H. van de Velde, Coen W. Hurkmans, Nicole Duez, Luigi Cataliotti, Jan Bogaerts, P. Meijnen
Publikováno v:
Annals of Surgical Oncology, 17(7), 1854-1861. Springer New York
Annals of Surgical Oncology
Annals of surgical oncology, 17(7), 1854-1861. Springer New York
Annals of Surgical Oncology
Annals of surgical oncology, 17(7), 1854-1861. Springer New York
Background The randomized EORTC 10981-22023 AMAROS trial investigates whether breast cancer patients with a tumor-positive sentinel node biopsy (SNB) are best treated with an axillary lymph node dissection (ALND) or axillary radiotherapy (ART). The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19dd3a452fd51f081311882d13c6fea
https://dare.uva.nl/personal/pure/en/publications/sentinel-node-identification-rate-and-nodal-involvement-in-the-eortc-1098122023-amaros-trial(4011efb6-dcb4-4af0-896c-506c04896458).html
https://dare.uva.nl/personal/pure/en/publications/sentinel-node-identification-rate-and-nodal-involvement-in-the-eortc-1098122023-amaros-trial(4011efb6-dcb4-4af0-896c-506c04896458).html
Autor:
Cornelis J.H. van de Velde, Grard A. P. Nieuwenhuijzen, Helen A. Westenberg, M. Donker, Marieke E. Straver, Robert E. Mansel, Lorenzo Orzalesi, Willem H. Bouma, Nicole Duez, Coen W. Hurkmans, Leen Slaets, Huub van der Mijle, Geertjan van Tienhoven, Sanne C. Veltkamp, Jan Bogaerts, Carlo Messina, Emiel J. Th. Rutgers, P. Meijnen
Publikováno v:
Journal of Clinical Oncology. 31:LBA1001-LBA1001
LBA1001 Background: Sentinel node biopsy (SNB) is standard in assessing axillary lymph node status for cN0 breast cancer patients. In case of a positive SNB, if treatment is advised, axillary lymph node dissection (ALND) is the current standard. Alth